Ernexa Therapeutics (ERNA) Institutional Ownership $1.33 +0.01 (+0.76%) As of 11:13 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Ernexa Therapeutics (NASDAQ:ERNA)CurrentInstitutional OwnershipPercentage70.55%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$1.04MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$1.41M Get ERNA Insider Trade Alerts Want to know when executives and insiders are buying or selling Ernexa Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data ERNA Institutional Buying and Selling by Quarter Ernexa Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails9/26/2025Corient Private Wealth LLC17,523$32K0.0%-93.3%0.228% 8/15/2025Corient Private Wealth LLC17,523$32K0.0%-93.3%0.228% 8/8/2025Geode Capital Management LLC20,075$37K0.0%-93.2%0.273% 2/12/2025Geode Capital Management LLC257,310$76K0.0%+1,159.2%4.756% 5/3/2024Avidian Wealth Solutions LLC14,798$36K0.0%N/A0.274% 5/2/2024Sippican Capital Advisors72,800$175K0.1%+34.7%1.346% 2/13/2024Lake Street Advisors Group LLC520,996$933K0.1%N/A9.630% 1/30/2024Sippican Capital Advisors54,050$97K0.1%+92.3%0.999% 1/1/2024Vanguard Group Inc.24,898$54K0.0%+30.6%0.460% 10/24/2023Sippican Capital Advisors28,100$61K0.1%+30.1%0.519% 2/1/2023Cypress Point Wealth Management LLC94,375$304K0.5%N/A3.210% 1/31/2023Naviter Wealth LLC79,621$387K0.1%N/A2.708% (Data available from 1/1/2016 forward) ERNA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ERNA shares? During the previous two years, the following institutional investors and hedge funds held shares of Ernexa Therapeutics shares: Lake Street Advisors Group LLC ($933K), Sippican Capital Advisors ($175K), Vanguard Group Inc. ($54K), Geode Capital Management LLC ($37K), and Avidian Wealth Solutions LLC ($36K), Corient Private Wealth LLC ($32K).Learn more on Ernexa Therapeutics' institutional investors. What percentage of Ernexa Therapeutics' stock is owned by institutional investors? 70.55% of Ernexa Therapeutics' stock is owned by institutional investors. Learn more on ERNA's institutional investor holdings. Which institutional investors have been buying Ernexa Therapeutics' stock? The following institutional investors have purchased Ernexa Therapeutics' stock in the last 24 months: Lake Street Advisors Group LLC ($521.00K), Geode Capital Management LLC ($236.88K), Sippican Capital Advisors ($51.20K), Avidian Wealth Solutions LLC ($14.80K), and Vanguard Group Inc. ($5.83K). How much institutional buying is happening at Ernexa Therapeutics? Institutional investors have bought a total of 236,875 shares in the last 24 months. This purchase volume represents approximately $1.04M in transactions. Which of Ernexa Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Ernexa Therapeutics stock in the last 24 months: Corient Private Wealth LLC ($490.68K), and Geode Capital Management LLC ($273.07K). How much institutional selling is happening at Ernexa Therapeutics? Institutional investors have sold a total of 763,751 shares in the last 24 months. This volume of shares sold represents approximately $1.41M in transactions. Related Companies ELUT Major Shareholders IOBT Major Shareholders PLUR Major Shareholders MURA Major Shareholders XFOR Major Shareholders ITRM Major Shareholders SCYX Major Shareholders TENX Major Shareholders RANI Major Shareholders XCUR Major Shareholders This page (NASDAQ:ERNA) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump’s “Smart Dollar” just went mainstream"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredOptions Pro Reveals His #1 Retirement Income TradeThe current market is creating a perfect setup for my favorite trading strategy — one that doesn’t rely on ris...Base Camp Trading | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ernexa Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ernexa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
